Gba Gene Mutation Clinical Trials
3 recruiting trials for Gba Gene Mutation. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Gba Gene Mutation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by New York Stem Cell Foundation Research Institute (1), Pacific Parkinson's Research Centre (1), Shaare Zedek Medical Center (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Biological Sample Collection (other, 1 trial), followed by PET scan, neuroQWERTY.
Track Gba Gene Mutation trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Drug Discovery for Parkinson's With Mutations in the GBA Gene
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the...
The GBA Multimodal Study in Parkinson's Disease
This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of...
World Data on Ambroxol for Patients With GD and GBA Related PD
Ambroxol hydrochloride is an oral mucolytic drug available over-the-counter for many years as cough medicine. In 2009 it was found to also act as a pharmacological chaperone (PC)...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Gba Gene Mutation, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Gba Gene Mutation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Gba Gene Mutation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.